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RNA polymerase pauses at different DNA sequences during
transcription elongation, and this pausing is associatedwith dis-
tinct conformational state(s) of the elongation complex (EC).
Transcription termination by the termination factor Rho, an
RNA-dependentmolecularmotor, requires pausing of the EC in
the termination zone of Rho-dependent terminators. We
hypothesized that the conformational state(s) of the EC associ-
ated with this pausing would influence the action of Rho. Anal-
yses of the pausing behavior of the EC at the termination points
of two well known Rho-dependent terminators revealed that
Rho prefers actively transcribing complexes for termination.
RNA release kinetics from stalled ECs showed that the rate of
RNA release by Rhowas reduced if the ECwas irreversibly back-
tracked, if itsRNAexit channelwasmodifiedby anRNAhairpin,
or the bridge helix/trigger loop movement in its active site was
perturbed. These defects were overcome significantly by
enhancing the rate of ATP hydrolysis either by increasing the
concentration of ATP or by using a Rho mutant with higher
ATPase activity.We propose that the force generated fromATP
hydrolysis of Rho is the key factor in dislodging the EC through
its molecular motor action, and this process is facilitated when
the EC is in a catalytically competent state, undergoing rapid
“Brownian ratchet” motion.
The highly processive and stable EC3 (1–3) dissociates from
template DNA only in response to transcription termination
signals. There are two types of termination signals in Esche-
richia coli. The intrinsic terminators are characterized by a
GC-rich inverted repeat followed by an oligo(dT) stretch
that destabilizes the EC and the factor-dependent termina-
tors, which depend on an essential protein, called Rho, for
termination (4, 5).
Rho is a homo-hexameric RNA/DNA helicase or translocase
capable of dissociating the elongating RNA polymerase from
the template DNA by utilizing its RNA-dependent ATPase
activity (6–8). It recognizes the Rho utilization (rut) site on the
exiting mRNA through its N-terminal primary RNA binding
domain (9). Binding of RNA to the primary binding site of Rho
guides the 3-side of the RNA into the central hole of the hex-
amer, which constitutes the secondary RNA binding domain.
Q-loop and R-loop are the two major RNA binding determi-
nants of Rho at this site. Interaction of the RNA with these two
loops activates ATP hydrolysis in the nearby P-loop region
(10–16).
The Rho-dependent termination region consists of a proxi-
mal 70–80-nt stretch of Cys-rich, unstructured RNA for bind-
ing of Rho (the rut site; see Refs. 17–19), followed by a distal
termination zone, dispersed over a wide range, beginning about
60–90 nts downstream of the rut site (reviewed in Ref. 20).
Analyses of Rho-dependent terminators revealed that the posi-
tion of the rut site determines the location of the downstream
termination zone (21–24). Unlike Rho-independent termina-
tors, the termination zone of the well characterized Rho-de-
pendent terminators, such as  tR1 and trp t, do not have char-
acteristic signatures, except that the sequences areAU-rich and
the termination points are associated with pausing of the EC
(25, 26). However, not all pause sites are termination points,
and these include some of the strongest pauses along a termi-
nator (27).
RNAP pauses during elongation at different sequences,
which provide an adequate time window for different cis and
trans factors to act upon the EC (28). Depending on the pause
sequence, the active site of the EC can be in conformationally
distinct states (28). Pausing at Rho-independent terminators is
required for the timely formation of an RNA hairpin at the exit
channel (29), although pausing in the termination zone of Rho-
dependent terminators is believed to help Rho to “catch up”
with the elongating EC (7).
The importance of conformational state(s) of the EC in Rho-
dependent termination has not been explored. As pausing of
the EC is associated with the termination points in the termi-
nation zone (25, 26), we hypothesized that the conformational
state(s) associated with pausing would affect the RNA release
process by Rho. Quantitative analyses of the EC paused at the
termination points, and RNA release kinetics from the stalled
ECs with different conformational states show that Rho prefers
actively transcribing complexes for termination. These assays
also reveal that an enhanced rate of ATP hydrolysis is required
to release RNA from the catalytically inactive ECs.We propose
that the force generated by ATP hydrolysis of Rho is the key
factor in dislodging the EC through its molecular motor action,
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and the process is facilitated when the EC is in a catalytically
competent state undergoing rapid “Brownian ratchet” motion.
EXPERIMENTAL PROCEDURES
Materials—NTPs, poly(C), IPTG, lysozyme, dithiothreitol,
and bovine serum albuminwere fromGEHealthcare. Radioiso-
topes [-32P]ATP (6000 Ci/mmol) and [-32P]CTP (4500
Ci/mmol) were purchased fromeitherGEHealthcare or Jonaki,
BRIT, India. Primers for PCR were obtained either from Sigma
orMWGBiotec. Restriction endonucleases and T4DNA ligase
were from New England Biolabs. WT E. coli RNA polymerase
holoenzyme and tagetitoxin were purchased from Epicenter
Biotechnologies. TaqDNA polymerase was from Roche
Applied Science. Streptavidin-coated magnetic beads were
from Pierce. Streptolydigin was from Chemcon, Germany.
Cloning, Overexpression, and Purification of Proteins—The
purification of LacR, NusA, NusG, His-tagged and nonHis-
taggedRhowas performed as described previously (30, 31).His-
tagged E. coli GreB was cloned in pET21b and purified using
nickel-nitrilotriacetic acid beads. P235H Rho (pRS630) was
prepared by site-directed mutagenesis (Stratagene) of pRS96,
using the primers RS345 and RS346, and was purified as
described earlier (31).
Templates for in Vitro Transcription—T7A1-trp t and
T7A1- tR1 templates for pausing assays, used in Fig. 1, were
made by PCR amplification using RS58/RS140 primers with the
plasmid pRS106 (31) and RS58/RS147 primers with plasmid
pRS604, respectively. To immobilize the templates on strep-
tavidin-coated magnetic beads (Promega), a biotinylated
upstream primer RS83 was used in all cases. Primers with lac
operator, ops pause, and his pause sequences were used in PCRs
to incorporate these sequences in the termination zone of the
trp t terminator. Details of the primers and plasmids are
described in Table 1.
Pausing Kinetics Assays—All in vitro transcription assays
were performed in T buffer (25 mM Tris-HCl, pH 8.0, 5 mM
MgCl2, 50 mM KCl, 1 mM dithiothreitol, and 0.1 mg/ml bovine
serum albumin) at 37 °C. The reactions were initiated with 10
nMDNA template, 40 nMWTRNApolymerase, 175MApU, 5
M each of GTP andATP, and 2.5M of CTP tomake a 23-mer
elongation complex (EC23). [-32P]CTP (3000 Ci/mmol) was
added to the reaction to label the EC23. EC23 was then chased
with 20 M NTPs in the presence of 10 g/ml rifampicin, and
aliquots were removed at different time points and mixed with
formamide loading dye (Fig. 1,A and B). Transcripts were frac-
tionated by electrophoresis on a 10% sequencing gel, and the
gels were scanned and analyzed by Typhoon 9200 Phosphor-
Imager. Pausing assays on ops (Fig. 3B) and his (Fig. 4B) pause
templates were performed essentially in the same way as
described above, except that EC23 was chased with 10 M GTP
and 100 M other NTPs.
Rho-mediated RNA Release Assays from Stalled Elongation
Complexes (RB; Road-blocked Complex)—These assays were
performed in T buffer using immobilized templates with lac
operator sequences at different positions in the termination
zone of the T7A1-trp t template (Figs. 2–4). The templates
were immobilized before starting the reaction. Transcription
TABLE 1
Oligos and plasmids used in this study
Description
Oligo
RS58 ATAAACTGCCAGGAATTGGGGATC; located upstream of T7A1 promoter of pRS106
RS83 ATAAACTGCCAGGAATTGGGGATC; 5-biotinylated RS58
RS139 TTAATACGACTCACTATAGGGAGATCGAGAGGGACACGGGCG. T7 -10 promoter fused to the start site of T7A1 promoter
RS140 GTCCGGATTGGAGCTTGGGATCC; reverse oligo at BamHI site of pRS106
RS146 GCGCGCAAGCTTGCGATCAACAAGGCCATTCATGC,  tR1 forward primer with HindIII site
RS147 GCGCGCGGATCCCCCCATTCAAGAACAGCAAGCAGC, reverse oligo to generate T7A1- tR1 terminator template
RS177 TTGTGAGCGCTCACAATTCGGATATATATTAACAATTACCTG; reverse oligo with lac operator sequence, used to generate roadblock
downstream of rut sites of T7A1-trp t template
RS270 GCGCGCCATATGAAAACGCCCCTGGTTACCCG, forward primer with NdeI site to amplify E. coli greB gene
RS272 GCGCGCCTCGAGCGGTTTCACGTACTCGATAGCATTAAC, reverse primer with XhoI site, without stop codon, to amplify E. coli greB
RS275 GGAATTGTGAGCGCTCACAATTCCTTCCAGCACACATCGCCTGAAAGACTAG; reverse oligo with lac operator sequence 4 nt
downstream of the his pause position, used for PCR amplification with RS83/RS307 on his pause template
RS302 GAATTGTGAGCGCTCACAATTCTTAGGAAAATTATTGATTTACTG; reverse oligo with lac operator sequence; used to generate
roadblock downstream of T7A1 promoter
RS307 AGCACACATCGCCTGAAAGACTAGTCAGGATGATGGTGATATATTAACAATTACCTG; reverse oligo with his pause sequence; specific for
T7A1-trp t template
RS314 AGTGACTTAGAGAAAAAAGCACGCTACCGCCTGGCCTAGGTGTTATGTTGCGGGATT; reverse primer with ops pause sequence from
rfaQ gene; used downstream of T7A1 promoter
RS315 GGAATTGTGAGCGCTCACAATTCAAGCACGCTACCGCCTGGCCTA; reverse oligo with lac operator fusion 4 nt downstream of ops
pause site; used on RS83/RS314 template
RS319 AGTGACTTAGAGAAAAAAGCACGCTACCGCCGAGGAATAAGTGACTTAGAG; reverse oligo with lac operator sequence, used to generate
roadblock downstream of T7A1 promoter and rut sites
RS320 GGAATTGTGAGCGCTCACAATTCAAGCACGCTACCGCCGAGGAATAAGTGACTTAGAG; reverse oligo with lac operator fusion 4 nt
downstream of ops pause site; used with RS83/RS319 template
RS341 GAA TTG TGA GCG CTC ACA ATT C GGATCCTTAGATAACAATTGATTGAATG; 67 nt downstream of  nutR site
RS345 GCTTCTACCTTTGACGAACACGCATCTCGCCACGTTC, primer 1 for site-directed mutagenesis to make P235H Rho
RS346 GAACGTGGCGAGATGCGTGTTCGTCAAAGGTAGAAGC, primer 2 for site-directed mutagenesis to make P235H Rho
Plasmids
pRS22 See Ref. 30
pRS96 See Ref. 31
pRS103  tR1 fragment cloned at HindIII/BamHI site of pRS22
pRS106 See Ref. 50
pRS604 T7A1- tR1 fragment cloned at HindIII site of pRS22
pRS630 P235H Rho cloned at XhoI/NdeI site of pET 21b, His-tagged at C terminus
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reactions were initiated as above except that 100 nM of lac
repressor was added before making the EC23 complex. EC23
complex was then chased in the presence of 100 M NTPs and
rifampicin for 2 min to make the RB complexes. RB complexes
were made in a similar manner on all the templates. These
complexes were then immediately washed three times with 150
l of T buffer to remove the excess NTPs and resuspended in
the same buffer. The washing steps were completed within 5
min to avoid long incubation of the stalled ECs. 50 nM Rho in
the presence of indicated amounts of ATP (either 25 M or 1
mM) was then added, and aliquots of the reaction mixture were
removed at different time points, and supernatant and bead
fractions were separated using a magnetic stand. Half of the
supernatant (“S”) was added to an equal volume of RNA loading
dye (Ambion), and the rest of the reaction (half of the superna-
tant  pellet; “P”) was phenol-extracted and mixed with the
same dye. In the experiments where antibiotics were used, the
RB complexes were incubated with either 300 M streptolydi-
gin or 60 M tagetitoxin for 5 min before the addition of Rho.
GreB and Pyrophosphate Cleavage Assays—To assess the
extent of backtracking of the stalled elongation complexes at
position 124 (Fig. 2B) and at ops pause site (Fig. 3B), the
respective RB complexes were prepared as described above.
The backtracked complex at124was observed to form readily
during the three washing steps, which were completed within 5
min. Then 0.5 M of GreB was added, and the cleavage reac-
tions were allowed to continue for 3 min. For pyrophosphate
(PPi)-mediated cleavage of the RB complex at the his pause
site, 1 mM sodium pyrophosphate was added, and aliquots of
the reaction mixture were removed at the indicated (Fig. 4C)
time points, and the reaction was stopped by mixing with
RNA loading dye.
Analyses of the Pausing and RNA Release Kinetics—For the
pausing assays, the amount of RNA in each pausing site (Fig. 1)
was quantitated using ImageQuant software and plotted
against time. The plots were fitted to the equation of expo-
nential decay (y  a exp(t)) to calculate the rate () of
escape from the paused site and efficiency of pausing (a) at
that site (stated as PE in Fig. 1). The intercept of this curve on
the y axis gives the value of “t1⁄2”, the pausing efficiency. The
half-lives (t1⁄2) of pausing were calculated from, t1⁄2  ln2/
(ln10).
To determine the rate of accumulation of Rho-mediated
released RNA (Figs. 2–5), the band intensities were quantitated
by ImageQuant software, and the fraction of released RNA
(2S/S  (S  P)) from each experiment was plotted against
time. The plots were fitted to the equation of exponential rise
(y  a(1  expt)) to calculate the rate () and maximum
efficiency (a) of RNA release. The error bars were calculated
from the standard deviations obtained from at least three
measurements. All the curve fittings were performed using
Sigmaplot.
ATPase Assays—The rate of ATP hydrolysis of WT Rho and
Rho P235Hwasmeasured by using RNAs containing the region
of well known Rho-dependent  tR1 and trp t terminators.
DNA templates for transcribing the RNA were prepared by
PCR amplification from the plasmid pRS604 using RS139/
RS341 oligo pairs, and from the plasmid pRS106 using RS139/
RS177 oligo pairs, to make the  tR1 and trp t terminator
sequence containing RNA fragments, respectively (Table 1).
Both the RNAs were made using the Mega transcript kit from
Ambion. The ATP hydrolysis was assayed by monitoring the
release of Pi fromATP using polyethyleneimine TLC plates and
0.75 M KH2PO4, pH 3.5, as a mobile phase under the following
conditions. The assayswere performed inT buffer (25mMTris-
HCl, pH 8.0, 50 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.1
mg/ml bovine serum albumin) at 37 °C. The rate of ATP
hydrolysis at 25M and 1mMof ATP together with [-32P]ATP
(3500 Ci/mmol; BRIT, India) were measured using 25 nM and
50 nM of Rho, respectively. Reaction was started by addition of
0.2Mof either tR1 or trp tRNA.Aliquotswere removed and
stoppedwith 1.5M formic acid at various time points depending
on the concentrations of ATP. Release of Pi was analyzed by
exposing the TLC sheets to a PhosphorImager screen and sub-
sequently by scanning using Typhoon 9200 (Amersham Bio-
sciences) and quantified by ImageQuant TL software. The
product formation was linear in the time range that we used for
calculating the initial rate of the reaction. The initial rates of the
reaction were determined by plotting the amount of Pi released
versus time using linear regression methods.
RESULTS
Pausing of ECs at the Termination Points of Rho-dependent
Terminators Is Associated with a Short Half-life—Earlier semi-
quantitative studies with two well known Rho-dependent
terminators, trp t and  tR1 (24, 25), described the pausing
of RNAP at the termination points in the termination zone of
these two terminators. To further characterize the nature of
these pauses, we cloned these two terminators under a strong
promoter like T7A1, and we measured pausing kinetics at the
major termination points (indicated by * in Fig. 1, A and B).
Band intensities corresponding to the pausing sites were plot-
ted against time and fitted to an exponential decay equation to
calculate the pause half-lives (t1⁄2) and pause efficiencies (Fig. 1,
shown below the autoradiograms). We observed that at all the
termination points, except at position 124 of trp t, the half-lives
of pausing are very short. This suggests that the nucleotide
addition cycle at these points is not hindered significantly, and
the ECs are in a catalytically active state. Even though the EC
pauses longer at position 124 of trp t than the other pausing
sites, it retains the competence for elongation at this point. We
also observed that the pausing efficiencies at the termination
points of the  tR1 terminator are higher than that of trp t
terminator. It should be noted that the difference in the RNA
sequences between the two terminators may also lead to the
difference in the ability of the Rho to act.
We concluded that although high efficiency pausing in the
termination zone is important for termination to occur, Rho
distinctly prefers catalytically active conformational states of
the EC. Transient pauses are preferred over long pauses for
releasing RNA by Rho.
Rationale and Design of RNA Release Assays from Stalled
ECs—To gain further insight into the preference of Rho for
particular conformational state(s) of the EC, we measured the
rates and efficiencies of RNA release by Rho from ECs in differ-
ent conformational states. We stalled elongation complexes
Elongation Complex Preferences of Rho
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(RB) at desired positions in the termination zone of the trp t
terminator using lac repressor as a roadblock (Fig. 1C) (32) so
that the behavior of Rho could be studied uncoupled from tran-
scription elongation.Weprepared four different types of stalled
ECs as follows: 1) catalytically active EC at position161 (Fig.
2); 2) an irreversibly backtrackedECat position124 (Fig. 2); 3)
a reversibly backtracked EC at ops pause site introduced at posi-
tion155 (Fig. 3) (33); and 4) catalytically inactive EC stalled at
his pause site at position199with an RNAhairpin at the RNA
exit channel (Fig. 4) (33–36). We also prepared stalled ECs at
position 161 with conformationally frozen active centers
using two antibiotics, tagetitoxin (37) and streptolydigin (38,
39). All these stalled ECsweremade on immobilizedDNA tem-
plates attached to magnetic beads, which facilitated the
removal ofNTPs after formation of the complexes. RNArelease
by Rho was initiated in the presence of ATP.
RNA-dependent ATPase activity of Rho is required for its
transcription termination activity (40, 41). We hypothesized
that change in the rate of ATP hydrolysis may have a direct
consequence on the rate of RNA release by Rho from the stalled
ECs. The ATP hydrolysis rate may be varied by changing the
ATP concentration or by using certain Rho mutant(s) with sig-
nificantly different ATPase activity. We measured the rate of
ATP hydrolysis on two RNA fragments containing the  tR1
and trp t terminator sequences under different conditions
(Table 2, A and B). Upon increasing the concentration of ATP
from 25 M to 1 mM, the rate of ATP hydrolysis increased to
7-fold for  tR1 and 9-fold for trp t RNA. We used a Rho
mutant, P235H, reported to have a higher rate of ATP hydrol-
ysis compared with WT (42). Consistent with this report, we
observed that in the presence of 25 M of ATP, the rate of ATP
hydrolysis of this mutant is 4-fold higher for  tR1 and
5-fold higher for trp t RNA compared with that observed for
WT Rho. Therefore, to elucidate the effect of rate of ATP
hydrolysis on the rate of RNA release by Rho, we compared the
RNA release kinetics from the stalled ECs under conditions of
low (25 M ATP) and high (1 mM ATP/P235H Rho) rates of
ATP hydrolysis.
It is believed that the free energy generated during the ATP
hydrolysis is required for the translocation of Rho along the
RNA (43). Therefore, it can be assumed that the translocation
speed along the RNA is proportional to the rate of ATP hydrol-
ysis. As the translocation speed of Rho remains the same in the
presence of a given concentration of ATP, the release kinetics
obtained from our experiments will be the measure of the rate
of RNA release from the stalled EC and not the rate of translo-
cation of Rho. The differences, if any, in the kinetics will reflect
the EC conformational state dependence of Rho action.
Arrested ECs Are Poor Substrates for Rho—Elongation kinet-
ics through the termination zone of the trp t terminator (Fig.
1A) revealed a long pause site at 124, which indicates that a
stalled EC at this point may backtrack significantly. We stalled
the EC at this position, and for comparison, we also stalled the
EC at position161 (Fig. 2A). Significant pausing of the ECwas
not observed at position 161 during the elongation process
(Fig. 1A). The backtracking potential of the stalled EC was
assayed bymeasuringGreB-induced cleavage of theRNAby the
EC.The stalled EC at position124was found to be sensitive to
GreB-mediated cleavage and could only elongate from this
FIGURE1.Analysesof pausingassociatedwith theRho-dependent termi-
nation points in trp t and TR1 terminators. Autoradiograms show the
elongation kinetics through the termination zones of trp t (A) and  tR1 ter-
minators (B). Right-most lane of each of the autoradiograms shows the termi-
nated RNA bands in the presence of Rho. The numbering next to the autora-
diogram in A denotes the positions of the terminated band with respect to
the transcription start site. The numberings (I–V) in autoradiogram B are the
positions of the terminated bands in the  tR1 terminator. Asterisk indicates
the paused bands corresponding to the positions of termination. Below each
autoradiogram the pause half-lives (t1⁄2) and pausing efficiencies (PE) corre-
sponding to each termination point (TP) are shown. RO denotes run-off tran-
script. C, schematic showing the design of the stalled elongation complex
(RB) at different positions of the trp t terminator zone. The DNA template
consists of a T7A1 promoter followed by rutA and rutB sites and the termina-
tion zone of trp t terminator. The lac operator sequence was introduced at
different positions to stall the elongation complex in the presence of the lac
repressor. The sequence of the termination zone is describedbelow the sche-
matic. To these different RBs either WT or P235H Rho were added to initiate
RNA release reactions.
TABLE 2
ATPase activity under different conditions
The errors were calculated from 3 to 4 independent measurements. The fold
increase in the rate of ATPhydrolysis under different conditionswas expressedwith
respect to that obtained with the WT Rho in the presence of 0.025 mM ATP.
Rho ATP Rate of ATPhydrolysis Fold increase
mM nmol/min/g Rho
A.  tR1 RNA
WT 0.025 0.22 0.03 (1)
WT 1.0 1.49 0.08 6.7
P235H 0.025 0.86 0.08 3.9
P235H 1.0 4.58 0.57 20.8
B. trp t RNA
WT 0.025 0.16 0.03 (1)
WT 1.0 1.51 0.17 9.4
P235H 0.025 0.87 0.01 5.4
P235H 1.0 5.95 0.44 37.2
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position in the presence of GreB (Fig. 2B). From the size of the
cleavage product, we estimated that the EC at position 124
was backtracked by 8–9 nucleotides. This suggests that the
stalled EC at 124 was arrested and irreversibly backtracked.
On the other hand, stalled EC at161 was readily elongated in
the absence of GreB andwas not significantly sensitive to GreB,
which is indicative of its catalytic competence (Fig. 2B).
We then followed the time course of RNA release from these
two ECs in the presence of either WT or P235H Rho and 1 mM
ATP (Fig. 2, C–F). Rho released the RNA from the catalytically
active stalled EC at position 161 with a high rate and effi-
ciency, whereas the rate of RNA release was 4-fold and the
efficiency was 2-fold less for the arrested stalled EC at posi-
tion 124 (Fig. 2, C and E). The rate and efficiency of RNA
release were drastically improved when the124 EC was acti-
vated in the presence of GreB (Fig. 2E). A similar improvement
was also observed in the presence of a mutant Rho, P235H,
which has a higher rate ofATPhydrolysis (42) (Table 2; Fig. 2,D
and F). These results indicate that irreversibly backtracked ECs
are a poor substrate for Rho, and a higher rate ofATPhydrolysis
is required to dislodge them.
Reversible Backtracking of EC
DoesNotAffect Rho-dependent RNA
Release—The ops pause sequence
induces pausing because of reversi-
ble backtracking of the EC (33). We
analyzed Rho-mediated RNA
release from the ops pause site
introduced within the termination
zone of the trp t terminator (Fig.
3A). Efficient pausing was observed
at the ops pause sequence in this
context as was revealed from the
elongation kinetics through this
sequence (Fig. 3B). Also, the intro-
duction of this site in the trp t ter-
mination zone did not affect Rho-
dependent termination (Fig. 3B).
ECs stalled at this pause site were
sensitive to GreB cleavage but were
also efficiently elongated both in the
presence and absence of GreB (Fig.
3B, right panel). This suggested that
the stalled EC at the ops pause site in
the trp t termination zone was
reversibly backtracked and was cat-
alytically active.
Next Rho-dependent RNA re-
lease from the stalled ECs at ops site
and at 161 were carried out in the
presence of 25 M ATP as in Fig. 2
(Fig. 3, C and D). Rho released RNA
fromthe stalledECat theops sitewith
comparable rate and efficiency as that
from position 161. Therefore, Rho
can release RNA efficiently from a
reversibly backtracked EC which is
catalytically active.
Catalytic Inactivation of EC by an RNA Hairpin at the Exit
ChannelCauses Inefficient Rho-dependent RNARelease—Paus-
ing at the his pause sequence is proposed to be mediated by
interaction of an RNA hairpin with the flap domain of the
-subunit of RNAP located near the RNA exit channel (33–36).
The sequence at the his pause site codes for RNA that folds into
a hairpin near the exit channel. Hairpin-EC interaction at this
site was found to cause catalytic inactivation, most likely by
allosterically hindering the movement of the trigger-loop (TL)
structural element (44). We tested the effect of this his hair-
pin-modified EC on Rho-mediated RNA release. There were
two reasons for choosing this modified EC. (i) We observed
in Fig. 2 that catalytically inactive, arrested EC is a poor
substrate for Rho. The his hairpin-EC interaction also causes
catalytic inactivation. However, this inactivation is not
because of irreversible backtracking of the EC, but because of
altered conformations at the active site (44), which is distinct
from the conformation of the EC at position 124 (Fig. 2).
(ii) If the interaction of Rho with the EC is required for its
action, the likely region of interaction will be the RNA exit
channel. The his hairpin causes conformational changes in
FIGURE 2. Arrested stalled ECs are poor substrates of Rho. A, RNA sequences of the two templates used to
make the stalled elongation complexes at124 and at161 positions. The sequences of RNA present in the
RNA:DNA hybrid at these positions are shown in the boxwith the 3 nucleotide highlighted. B, autoradiogram
showing the positions of the stalled complexes (RB), run-off products (RO) and GreB-mediated cleavage prod-
ucts under different conditions. Lanes 3 and 8, RB was first made and then chased by adding IPTG and NTPs.
Lanes 5 and 10, cleavage was first induced by GreB, and the cleaved products were then chased with IPTG and
NTPs. Fraction of chased complexes were calculated from the band intensities of different products as (RB)/
(RB RO). Autoradiograms showing the time course of RNA release from the stalled elongation complexes at
positions124 and161 position in the presence ofWT (C) and P235H (D) Rho. S (half of the supernatant) and
P (half of the supernatantpellet) denote the amount of released RNA and total RNA, respectively. Represent-
ative time points are indicated. The plots of fraction of released RNA were plotted against time for WT (E) and
P235H Rho (F). The curves were fitted to an exponential rise equation, and rates of RNA release, stated in the
inset of each panel, were calculated as described under “Experimental Procedures.”
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this part of the EC and may also block the approach path
of Rho.
We introduced the his pause sequence downstream of posi-
tion161 in the termination zone of the trp t terminator (Fig.
4A). Elongation kinetics, using this construct, revealed an effi-
cient pause 12 nt downstream of the his hairpin (199), which
suggested that the his pause sequence is functional in this con-
text (Fig. 4B).We also tested the hairpin-induced catalytic inac-
tivation of the EC at this pause site, which is indicative of the his
hairpin-EC interaction at this site.We stalled the EC at199 by
adding lac repressor to the reaction and monitored the pyro-
phosphate cleavage potential of the EC. This is ameasure of the
catalytic competence of the EC when transcription elongation
is blocked by the lac repressor (45). We observed very ineffi-
cient pyrophosphate cleavage (Fig. 4C), indicating that the his
hairpin in our construct can efficiently cause catalytic inactiva-
tion of the EC. Therefore all the properties of his hairpin-mod-
ified ECwere reproduced in our construct, and it can be used to
study the effect of this modified EC on Rho-dependent RNA
release.
We measured RNA release kinetics by either WT or P235H
mutant Rho from the EC stalled at the his pause site, in the
presence of either low (25M) or high (1mM) concentrations of
ATP (Fig. 4,D–G). The kinetics of RNA release at the his pause
site was compared with that obtained from catalytically active
EC at position 161. The rate and efficiency of RNA release
were found to be reduced significantly at the his pause site as
compared with that obtained at position161 (Fig. 4E). How-
ever, the rate and efficiency of RNA release were improved
under the regimen of higher rate of ATPhydrolysis either in the
presence of 1 mM ATP (Fig. 4F) or P235H Rho (Fig. 4G). Anal-
ogous to the arrested complex in Fig. 2, Rho can efficiently
dislodge the catalytically inactive his hairpin-modified EC only
when the rate of ATP hydrolysis is higher. A part of the energy
fromATP hydrolysismay also be used by Rho to unwind the his
hairpin.
Effects of the Elongation Inhibitors Tagetitoxin and Streptoly-
digin on Rho-dependent RNARelease—Results described above
strongly suggest that the functional state(s) of the active site of
the EC is important for the substrate specificity of Rho. NTP
addition cycle during transcription elongation involves the
movement of the two important structural elements, the bridge
helix (BH) and the trigger loop (TL), located close to theMg(II)-
binding site, and their movement determines the functional
state of the active site (46, 47). We hypothesized that any per-
turbations in the conformational state(s) of these two structural
elements will affect Rho-dependent RNA release from the EC.
We modified the EC stalled at position161 with two anti-
biotics, streptolydigin (STL) and tagetitoxin (TGT), which bind
close to the BH and TL structural elements (Fig. 5A) (37, 47)
and hinder the movement of these two elements. The STL-
bound EC is capable of adding only one nucleotide (38, 39, 48),
whereas NTP addition cycle is completely blocked in the TGT-
bound form (37). This suggests that in the TGT-bound EC, BH
and TL movement may be impermissible, whereas in the STL-
bound form these two elements may have limited freedom to
move. The modifications of the stalled EC at position 161
with these two antibiotics were at first confirmed from their
inability to be elongated efficiently after treating the RBs with
IPTG and NTPs (Fig. 5B).
We then measured RNA release kinetics by Rho from these
modified stalled ECs (Fig. 5, C–G). The rate of RNA release by
Rho was 2-fold lower when the ECwas bound to TGT (Fig. 5,C
and E). This rate, however, improved when P235H mutant
instead ofWTRhowas used (Fig. 5F). Therefore, when internal
motion around the active site is impaired, Rho requires a higher
rate of ATP hydrolysis to dislodge the EC. Interestingly, Rho
was able to dislodge the STL-bound EC efficiently (Fig. 5,D and
G). The STL-bound form offers a little more freedom of move-
ment to the BH and TL elements (38, 39) compared with the
FIGURE 3. Rho releases RNA efficiently from reversibly backtracked ECs.
A, RNA sequence coded from the ops pause site (in boldface italic) introduced
in the trp t termination zone is shown. The 3-end of the RNA in the RB is at
position 151. RNA sequences coded from the trp t terminator zone sur-
rounding position161 are also shown. Region of RNA present in the RNA:
DNA hybrid is box. B, left panel shows the autoradiogram of the elongation
kinetics through ops pause sequence. Ops pause site is indicated with an
arrow. The right-most lane of this panel shows Rho-dependent termination
from this regionwith the terminated bands indicated by an asterisk. The right
panel shows the stalled EC (RB) at the ops pause site (lane 1). This complex is
subjected toGreB induced cleavage (lane 2) or chased in the presence of IPTG
and NTPs either in the absence of GreB (lane 3) or after incubating with GreB
(lane 4). C, autoradiogram showing the RNA release time course from stalled
ECs at ops pause site and position161 with corresponding plots are shown
in D. All the notations and calculations of the rates are same as in Fig. 2.
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TGT-bound form (37), which might be sufficient for Rho to
exert its action. As the BH/TL movement plays an important
role in Rho action, it is likely that hindered TLmovement in the
his hairpin-modified EC (44) may have also affected the effi-
ciency of RNA release by Rho from that complex (Fig. 4).
DISCUSSION
Pausing of the EC in the termination zone of Rho-dependent
terminators is required for coupling the transcription elonga-
tion and the translocation of Rho (24, 25). ECs can exist in
different conformational states at these pause sites (28). Here
we present strong evidence that the rate and efficiency of RNA
release by Rho are highly influenced by the conformational
states of the EC in the termination zone. We showed the fol-
lowing: 1) pausing associated with
the termination points is very short
lived (Fig. 1); 2) irreversibly back-
tracked (Fig. 2) and his hairpin-
modified ECs are poor substrates
for Rho (Fig. 4); 3) RNA release by
Rho is affected if the free movement
of BH/TL structures in the active
site of the EC is blocked completely
by the inhibitor tagetitoxin (Fig. 5);
and 4) increase in the rate of ATP
hydrolysis by Rho (Table 2, A and B)
is proportional to an increase in the
rate of Rho-dependent RNA release
from different stalled ECs. A higher
rate of ATP hydrolysis by Rho is
essential to release RNA efficiently
from the catalytically inactive ECs
(Figs. 2, 4, and 5). We concluded
that the dislodging of the EC by Rho
is facilitated only when the RNAP is
engaged in active transcription.
It has been proposed that a com-
plex Brownian ratchet motion
involving the oscillation of the two
structural elements, BL and TL, in
the active center governs the nucle-
otide addition cycle during elonga-
tion (46). Structural and biochemi-
cal evidence suggests that catalytic
inactivation of the ECs, modified
either by the his hairpin (44) or by
the antibiotic TGT (37), is because
of blockage of the movement of BL
and TL structural elements. The
oscillation of these two structural
elements is also likely to be hindered
when the 3-end of the RNA occu-
pies the secondary channel in an
arrested or irreversibly backtracked
complex.We showedhere that Rho-
dependent RNA release is signifi-
cantly affected in all these modified
ECs, which suggests that conforma-
tional flexibility around the active center plays a key role in the
process of termination. This suggestion is further supported by
the fact that Rho can efficiently release RNA from a reversibly
backtracked complex, where presumably the Brownian ratchet
motion is not hindered, and from an STL-bound EC where
some movement of BH and TL is allowed (38, 39).
What is the role of ATP hydrolysis during Rho-mediated
RNA release from the EC? We observed that there is a direct
correlation between the rate of ATP hydrolysis by Rho and its
efficiency of RNA release from the stalled ECs. ATP hydrolysis
by Rho is required for its transcription termination function
(40, 41). Although there is no direct evidence, it is believed that
the free energy derived from this ATP hydrolysis is used for the
translocation as well as the motor action of Rho (43). We spec-
FIGURE4.Catalytic inactivationofECscausedbyRNAhairpinat theexit channelaffectsRho-dependentRNA
release.A, RNA sequence showing the position of the hispause sequence downstreamof161 in the trp t termi-
nator zone. hispause hairpin-forming sequence is shown in the dotted box, and the pause site at199 is indicated
by an arrow. lac operator sequence after the pause site is also indicated. Region of RNA present in the RNA:DNA
hybrid ismarkedby a solid box. B, autoradiogramshowing the elongation kinetics through thehispause sequence.
his pause site and the run-off (RO) product are indicated. C, autoradiogram showing the pyrophosphorolysis reac-
tions (PPi cleavage)of the stalledEC (RB) at thehispause site in thepresenceof 1mMsodiumpyrophosphate for the
indicatedtimes.D,autoradiogramshowingthetimecourseofRNAreleasefromstalledECatthehispausesitebyWT
andP235HRho in thepresenceof 25MATP. Representative timepoints are indicated. Theplots corresponding to
the RNA release kinetics from the RB complexes at the his pause site under different conditions are shown in E–G.
Rates are indicated in the inset of each panel. All the calculations and notations are as in Fig. 2.
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ulate that increase in the rate of ATP hydrolysis will also
increase the translocation speed of Rho and will impart more
kinetic energy to this molecular motor. This kinetic energy will
be used by Rho to exert force on the elongation complex to
dislodge it. A higher rate of ATP hydrolysis will ultimately be
translated into a higher force that will enable Rho to act upon
the poor substrates.However, this hypothesis can only be tested
by a direct measurement of the force exerted by Rho using
single molecule measurements. Alternatively, it may be possi-
ble that each ATP hydrolysis step by Rho is directly linked to
each step of RNA release and later may involve successive steps
of pulling the RNA out of the EC or pushing the EC forward. In
this model, it is likely that under the regimen of a higher rate of
ATP hydrolysis, the steps involved in RNA release will become
faster and will outperform the NTP addition cycle of the EC.
However, linking ATP hydrolysis to the steps of RNA release
will also involve the utilization of the energy obtained from the
hydrolysis reactions.
Why does Rho prefer catalytically competent ECs for termi-
nation? At the peak of the elongation process, the rapid Brown-
FIGURE 5.Movement of bridge helix and trigger loop in the active center of the EC is important for Rho action. A, view of the nucleic acid framework in
the structure of elongation complex bound with STL is shown in the left panel. A similar view of TGT-bound RNA polymerase is shown in the right panel. The
images were prepared from the structural coordinates available from Protein Data Bank (2PPB (48) and 2BE5, (37)) using RASMOL. The BH and TL structures in
both figures are highlighted inblue andpink, respectively. The locations of antibiotics andMg(II) in both figures are shownas red and cyan spheres, respectively.
The rest of the RNAP structures are shown in a gray background. B, autoradiograms showing the chasing kinetics of the stalled ECs (RB) at position 161
modified with the STL and TGT. RB complexes were first incubated with respective antibiotics for 5 min and were then chased with IPTG and NTPs. Triangles
indicate the increasing time points ranging between 0 and 5 min. Autoradiograms showing the representative time points of the time course of RNA release
from the stalled elongation complexes at position161 modified either with tagetitoxin (C) or with streptolydigin (D). The concentration of ATP was 25 M.
Corresponding plots for RNA release kinetics under different conditions are shown in E–G. Calculations of the rates of RNA release were performed as in Fig. 2.
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ian ratchet motion at the active center of the EC will cause
breakage and formation of multiple noncovalent interactions,
whichmay confer overall instability to the EC as comparedwith
when it is trapped in a static conformation incapable of pursu-
ing nucleotide addition cycles. According to our speculation,
less force generated by the lower rate of ATP hydrolysis by Rho
is sufficient to dissociate these relatively less stable catalytically
active ECs, whereas an enhanced rate of ATP hydrolysis is
required to act on the more stable inactive complexes.We pro-
pose that Rho employs a “brute force” mechanism to dislodge
the EC, in which the force generated by the ATP hydrolysis sets
off its molecular motor action, which in turn displaces the EC.
This proposal is consistent with the recent observation that
translocation of Rho can break a strong biotin-streptavidin
interaction present at the end of an RNA template (49).
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